Abstract:Hepatocellular carcinoma (HCC) represents a major global health concern, demanding a thorough understanding of its molecular mechanisms for effective therapeutic strategies. RNA-binding proteins (RBPs) play critical roles in post-transcriptional gene regulation, with their dysregulation increasingly recognized as a hallmark of various cancers. However, the specific contributions of RBPs to HCC pathogenesis and prevention remain incompletely understood. In this study, we systematically conducted an examination of the expression profiles and clinical relevance of RBPs in 556 clinical samples from well-established cohorts. Through comprehensive analyses, a subset of RBPs exhibiting significant overexpression in HCC was identified, establishing a noteworthy correlation between their aberrant expression and HCC progression. Furthermore, 40S ribosomal protein S5 (RPS5), a ribosomal protein, emerged as a potential key contributor in HCC progression. Rigorous analyses established a correlation between elevated RPS5 expression and advanced clinicopathological features, suggesting its potential as a prognostic biomarker. Experiments further confirmed the impact of RPS5 on pivotal cellular processes implicated in cancer progression, including cell proliferation and metastasis. Further mechanistic studies unveiled the potential of RPS5 to activate the cell cycle by binding to key molecules involved in the pathway, thereby promoting the malignant progression of HCC. Additionally, our analysis of the etiology behind RPS5 overexpression in HCC posited it as an outcome of transcriptional regulation by the transcription factors Nuclear Respiratory Factor 1 (NRF1) and MYC-associated zinc finger protein (MAZ). In conclusion, our study contributes to the growing evidence elucidating the intricate involvement of RBPs, exemplified by RPS5, in the malignant progression of HCC. The integration of genomic, transcriptomic, and functional analyses provides a comprehensive understanding of the regulatory mechanisms associated with RPS5 in HCC. This comprehensive analysis not only advances our knowledge of the molecular drivers behind HCC but also highlights the potential therapeutic relevance of targeting RBPs and their regulatory network for the development of more effective treatment strategies.

The role of ribosomal proteins in the regulation of cell proliferation, tumorigenesis, and genomic integrity

Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications

Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer

Ribosomal Proteins and Cancer

Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy

Ribosomal Proteins and Colorectal Cancer.

Targeting ribonucleotide reductase for cancer therapy.

Ribosomal proteins in hepatocellular carcinoma: mysterious but promising

Decoding ribosome complexity: role of ribosomal proteins in cancer and disease

The Roles of RRP15 in Nucleolar Formation, Ribosome Biogenesis and Checkpoint Control in Human Cells.

Ribosomal Proteins: Functions Beyond the Ribosome.

Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy.

The Regulation of Protein Translation and Its Implications for Cancer

The Tristetraprolin Family of RNA-Binding Proteins in Cancer: Progress and Future Prospects

Ribosomal Protein S27-like is a Physiological Regulator of P53 That Suppresses Genomic Instability and Tumorigenesis

Patterns of ribosomal protein expression specify normal and malignant human cells

Multifaceted functions of RPS27a: An unconventional ribosomal protein

Abstract 3747: RPS3 positively regulates nucleotide excision repair with respect to XP-D and skin cancers

Advances in the Relationship Between Regulator of Ribosome Synthesis 1 (RRS1) and Diseases

Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma

Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapies